
    
      This was an open label, balanced, and randomized, two-treatment, two-period, two-sequence,
      single-dose, crossover bioavailability study planned on 32 healthy, adult, human subjects
      under fasting conditions. 31 subjects completed both the periods of the study. Both periods
      were separated by a washout of twelve days The study was conducted on 32 healthy, adult,
      human subjects under fasting conditions. 31 subjects completed both the periods of the study
    
  